Cardiology

Tirzepatide reduces LV mass and paracardiac fat in obesity-related HFpEF, offering structural heart benefits beyond weight loss.

Olpasiran significantly lowers oxidized phospholipids on apolipoprotein B but has no impact on systemic inflammatory markers in cardiovascular disease.

Minimally invasive endoscopic ultrasound-guided radiofrequency ablation offers a safe and effective alternative to adrenalectomy for treating unilateral aldosterone-producing adenomas.

A large Spanish cohort study highlights the distinct clinical features, management, and outcomes of coagulase-negative staphylococcal endocarditis.

Study reveals distinct clinical features in patients with both cardiac sarcoidosis and ACM-associated genetic variants, aiding diagnosis.

Younger patients with hypertrophic cardiomyopathy face increased sudden cardiac death risk during high-intensity exercise, despite no link to traditional risk factors.

A novel cardiovascular risk score improves prediction of heart disease by assessing stress-related changes in vascular function.

The 2025 AHA report highlights ongoing disparities in cardiovascular health, urging clinicians to enhance prevention and early intervention efforts.